FindTrial
Sign In

A clinical study to compare the therapeutic efficacy of bark Psidium guajava and Terminalia arjuna on Hypertension

A study on Psidium guajava L. (Parevata) and the therapeutic efficacy of its bark on Hypertension. - HTNPG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073044
Enrollment
40
Registered
2024-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

S.V. Ayurvedic college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Uncomplicated Primary Hypertension Systolic Blood Pressure from above 130 mmHg to below 200 mmHg Diastolic Blood Pressure from above 85 mmHg to below 120 mmHg

Exclusion criteria

Exclusion criteria: Systolic Blood Pressure from below 130 mmHg to above 200 mmHg Diastolic Blood Pressure from below 85 mmHg to above 120 mmHg

Design outcomes

Secondary

MeasureTime frame
Sweating,Sleeeplessness.Timepoint: At baseline, 3rd week and 5th week—

Primary

MeasureTime frame
Patient get relief from Anxiety, Headache, PalpitationsTimepoint: At baseline, 3rd week and 5th week—

Countries

India

Contacts

Public ContactPosa Venkata Srikanth

S. V. Ayurvedic College and Hospital

pavansangu@gmail.com9493410914

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026